NCT04307147 NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy Status UNKNOWN Phase PHASE3
NCT04304352 Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients Status UNKNOWN Phase PHASE2
NCT04302441 A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy Status UNKNOWN Phase PHASE2
NCT04299113 Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04296162 Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID) Status COMPLETED Phase PHASE2
NCT04208854 Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC) Status UNKNOWN Phase N/A
NCT04145349 CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor Status COMPLETED Phase PHASE1/PHASE2
NCT04143906 Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT03997539 A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT03901339 Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT03891173 A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma Status TERMINATED Phase PHASE2
NCT03811418 A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer Status WITHDRAWN Phase PHASE3
NCT03801304 Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT03770299 An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease Status WITHDRAWN Phase PHASE2
NCT03656393 To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma Status UNKNOWN Phase PHASE3
NCT03620032 Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03618550 Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma Status RECRUITING Phase PHASE2
NCT03456076 A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3